IBRX-042

N/A

Report date: 2023/09/18 10:44:32

Base Information

Drug NameIBRX-042
Drug Alias NameIBRX-042
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUterine Cervical NeoplasmsUrogenital NeoplasmsHead and Neck Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunitybio Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunitybio Inc
Inactive CompaniesN/A
Active IndicationsUterine Cervical NeoplasmsUrogenital NeoplasmsHead and Neck Neoplasms +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A